ACL-D at 5km/h); conversely, although on average ACL-R subjects showed a trend towards hypercorrection of step length (greater reduction of step length in BW), this difference did not reach statistical significance (p=0.12 ACL-R vs.
(e) The ratio of open arm to total arm entries in the elevated plus maze showed a trend towards more open arm entries in J20 animals and a recovery of this in GluA2 G/G /J20 mice (Welch’s ANOVA W (3,29.15) = 2.12, p = 0.12; n’s : WT = 15, GluA2 G/G = 13, J20 = 16, GluA2 G/G /J20 = 14).
Similarly, the average number of cells per somite showed a trend toward an increase in the experimental group compared to controls (control vs. experiment: 237 ± 107 vs. 550 ± 117, p = 0.12, Figure 6c ), indicating that NAD(H) may promote the proliferation of PSM‐like progenitor cells.
Single-sample gene set enrichment analysis (ssGSEA) analysis revealed an inverse correlation between CLDN18 expression and CD8 + T cells ( P = 0.012), while IHC showed a trend toward negative correlation between CLDN18.2 expression and CD8 + TILs density ( P = 0.12).
11 However, a prospective, phase II, B-F1RST study only showed a trend toward a PFS benefit (hazard ratio (HR) = 0.66; 90% confidence interval (CI): 0.42–1.02; P = .12) and an OS benefit (HR = 0.77; 90% CI: 0.41–1.43; P = .48). 12 Cancer is a genetic disease, and multiple genetic mutations may lead to resistance to therapy, including immunotherapy. 13 Recent studies r
Although not statistically significant, patients treated with ICIs showed a trend toward better prognosis (P=0.12) than those not treated with ICIs [18.4 months (95% CI: 8.2–28.6) vs. 7.7 months (95% CI: 0–17.7)] ( Figure 2B ).
TGV showed a trend-level effect for the shorter-than-average sleepers ( P = 0.12).
In the subgroup analysis, patients with 3D-CRT/IMRT showed a trend of improved 5-year OS rate compared with conventional RT (100% vs. 86.9%, P =0.12).
Evaluation of sexual desire Meta-analysis incorporating 4 studies [ 19 , 20 , 27 ] showed a trend toward decreased sexual desire in SSRI users (RR = 1.40, 95% CI: 0.92–2.12, p = 0.12; I2 = 54%, 1,160 participants).
Although survival differences among infiltration groups did not reach statistical significance, T-cell infiltrated patients showed a trend toward improved outcomes ( online supplemental figure 2B ; HR=0.31, p=0.12).
For severe case-patients from Salvador collected <7 days of onset, the acute-phase sensitivity for DPP (77%, 66–85%) was superior to the 1:00 MAT screening titer (46%, 35–58%; P<0.001) and showed a trend toward superiority over the IgM-ELISA (65%, 54–76%; P = 0.12).
The inclusion of center-based cluster effects showed a trend towards ( P =0.12) improved model fit compared with fitting the same model using ordinary logistic regression with no clustering.
No notable differences were observed, but BMI in males showed a trend of increasing with age (p=0.12).
Interestingly, only the presence of T-cell reactivity against CT antigens showed a trend towards correlation with CRs ( p = 0.12).
CB patients also showed a trend toward higher 5 and 10 year regional control rates compared with SD patients (97.7% and 97.7% vs 97.1% and 82.9%, respectively; P = .12 for both) at 5 and 10 years, respectively.
One of the central hub genes KIF23 showed a trend toward association with poor survival (Hazard ratio = 2.2; p-value = 0.12), though this did not reach statistical significance, likely due to the limited sample size of CHOL in TCGA.
Meta-regression showed a trend toward lower CBT efficacy for positive symptoms with a higher SZA disorder proportion (β = +0.10 SMD per 10% increase in AP; p = 0.12), though it was not statistically significant.
In the group treated with carboplatin, the results showed a trend towards worse survival in TTF-1 − patients, with an OS of 1 month (95% CI: 0–2.3) compared to 4 months (95% CI: 0–10.4) in TTF-1 + patients (P=0.12).
The current density of p.I1498M showed a 59% reduction, whereas the other variants did not show statistically significant modifications (although p.R1636Q showed a trend towards reduction, P = 0.12).
Scintillation counts showed a trend for increased 3 H-glucose signal in IRβ-expressing cells (Student’s t -test; p = 0.120), which exhibited ∼30% more uptake than control cells ( Figure 1E ).
Analysis of dependency of BIS-reduction on daytime showed a trend for HGSHS-5 (BIS total intervention) with 88.8 at noon vs. 90.5 in the morning and evening ( p = 0.12).
In patients with newly diagnosed T2D ( Supplementary Table 7 ), the p.Trp325Trp carriers showed a trend (p = 0.12) towards enhanced β-cell sensitivity to glucose during the OGTT ( Extended Data Fig. 3c ).
The HMGXB4 mutation also showed a trend for association with worse RFS (HR, 2.5; 95% CI, 0.78–7.8; P = .12) ( Figure 14 ).
Moreover, Kaplan-Meier estimation of the survival ratio deduced from the same gene predictors showed a trend for improved survival of patients with non-recurrence expression patterns compared with those with the recurrence expression pattern ( P =0.12) (Figure 2 C, D).
Subgroup analyses showed a trend for the reduction in triglycerides in the EG to be larger at longer-term follow-up (i.e., 6–12 months; MD −0.16; 95% CI −0.37 to 0.04; p = 0.12; I 2 = 0%) than at 3 months (MD −0.06; 95% CI −0.27 to 0.15; p = 0.55; I 2 = 0%), but both effects were not significant ( Figure 5 ). 3.4.4.